Dopamine transporter imaging predicts clinically‐defined α‐synucleinopathy in REM sleep behavior disorder
Output Details
Published December 15, 2020
- Alpha-synuclein
- DAT imaging
- Original Research
Meet the Authors
-
Lana M. Chahine
External Collaborator
-
Michael Brumm
External Collaborator
-
Chelsea Caspell-Garcia
External Collaborator
-
Wolfgang Oertel
External Collaborator
-
-
Amy W. Amara
External Collaborator
-
Ana Fernandez-Arcos
External Collaborator
-
Eduardo Tolosa
External Collaborator
-
Cristina Simonet
External Collaborator
-
Birgit Hogl
External Collaborator
-
Aleksandar Videnovic
External Collaborator
-
Samantha Hutten
External Collaborator
-
Caroline M. Tanner
External Collaborator
-
Daniel Weintraub
External Collaborator
-
Elliot Burghardt
External Collaborator
-
Christopher S. Coffey
External Collaborator
-
Hyunkeun Ryan Cho
External Collaborator
-
Karl Kieburtz
External Collaborator
-
Kathleen Poston, MD
Stanford University
-
Kalpana Merchant, PhD
Northwestern University
-
Douglas Galasko
External Collaborator
-
Tatiana Foroud
External Collaborator
-
Andrew Siderowf
External Collaborator
-
Ken Marek, MD
University of California, San Diego
-
Tanya Simuni, MD
Northwestern University
-
Alex Iranzo
External Collaborator
Related Research
Post-fibrillization nitration of alpha-synuclein abolishes its seeding activity and pathology formation in primary neurons and in vivo
Increasing evidence points to post-translational modifications (PTMs) as key regulators of alpha-synuclein (α-Syn) function in health and disease. However, whether these PTMs occur before or after α-Syn pathology formation and their role in…
The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in human cell lines
The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in fibroblasts.
qPCR of α-synuclein, TNF and NF-κβ
A procedure for quantitative real time reverse transcription PCR of α-synuclein, TNF, and NF-κβ.